Mechanism of phytochemicals as anticancer agents in parcreatic carcinoma

doi:10.3760/cma.j.issn.1673-422X.2014.12.016

Abstract

Abstract: Pancreatic cancer remains a devastating disease with a 5year survival rate of less than 5%. Recent advances in diagnostic methods and therapeutic approaches have increased the possibility of improving the existing poorprognosis. Recently, compounds from naturalsources receive ample attention as anticancer agents. Overwhelming in vitro evidence and clinical trials suggest that curcuminn, isothiocyanate, capsaicin, catechin may reduce the incidence of cancer.

Key words: Curcumin, Isothiocyanate, Capsaicin, Catechin, Pancreatic neoplasms

DANG Jun-Qiang, CHEN Yuan, LIN Wen, LI Chang-Bin. Mechanism of phytochemicals as anticancer agents in parcreatic carcinoma[J]. Journal of International Oncology, 2014, 41(12): 930-933.

References

［1］ Block G, Patterson B, Subar A. Fruit, vegetables, and cancer prevention: areview of the epidemiological evidence［J］. Nutr Cancer, 1992, 18(1): 129. ［2］ Anand P, Sundaram C, Jhurani S, et al. Curcumin and cancer: an "oldage" disease with an "algeold" solution［J］. Cancer Lett, 2008, 267(1): 133164. ［3］ Li L, Aggarwal BB, Shishodia S, et al. Nuclear factor kappa B and I kappa B kinase are constitutively active in human pancreaticcells, and their downregulation by curcumin (diferuloylmethane) isassociated with the suppression of proliferation and the induction ofapoptosis ［J］. Cancer, 2004,101(10): 23512362. ［4］ Hidaka H, Ishiko T, Furuhashi T, et al. Curcumin inhibits interleukin 8production and enhances interleukin 8 receptor expression on the cellsurfaceimpact on human pancreatic carcinoma cell growth by autocrineregulation［J］. Cancer, 2002, 95(6): 12061214. ［5］ Jutooru I, Chadalapaka G, Lei P, et al. Inhibition of NF kappa B and pancreatic cancer cell and tumor growth by curcumin is dependent onspecificity protein downregulation［J］. J Biol Chem, 2010, 285(33): 2533225344. ［6］ Lin L, Hutzen B, Zuo M, et al. Novel STAT3 phosphorylationinhibitors exhibit potent growthsuppressive activity in pancreatic and breastcancer cells［J］. Cancer Res, 2010, 70 (6): 24452454. ［7］陈干涛, 白少华, 高志强. 姜黄素联合顺铂抗胰腺癌细胞增殖的效应［J］. 中国中西医结合消化杂志, 2008, 16(1): 2628. ［8］ Li Y, Revalde JL, Reid G, et al. Modulatory effects of curcumin on multidrug resistanceassociated protein 5 in pancreatic cancer cells［J］. Cancer Chemother Pharmacol, 2010, 10(7): 15151520. ［9］ BoraTatar G, DayangacErden D, Demir AS, et al. Molecular modifications on carboxylic acid derivatives as potenthistone deacetylase inhibitors: activity and docking studies［J］. Bioorg Med Chem, 2009, 17(14): 52195228. ［10］ Ali S, Ahmad A, Aboukameel A, et al. Increased Ras GTPase activity is regulated by miRNAs that can be attenuatedby CDF treatment in pancreatic cancer cells［J］. Cancer Lett, 2012, 319(2): 173181. ［11］ Kanai M, Yoshimura K, Asada M, et al. A phase Ⅰ/Ⅱ study of gemcitabinebased chemotherapyplus curcumin for patients with gemcitabineresistant pancreatic cancer ［J］.Cancer Chemother Pharmacol, 2011, 68(1):157164. ［12］ Sahu RP, Srivastava SK. The role of STAT3 in the induction of apoptosis inpancreatic cancer cells by benzyl isothiocyanate［J］. J Natl Cancer Inst, 2009, 101(3): 176193. ［13］ Xu Q, Briggs J, Park S, et al. Targeting Stat3 blocks both HIF1 and VEGF expression induced by multiple oncogenic growth signalingpathways ［J］. Oncogene, 2005, 24(36): 55525560. ［14］ Schlieman MG, Fahy BN, Ramsamooj R, et al. Incidence, mechanism and prognostic value of activated AKT in pancreas cancer［J］. Br J Cancer, 2003, 89(11): 21102115. ［15］ Batra S, Sahu RP, Kandala PK, Srivastava SK. Benzyl isothiocyanatemediated inhibition of histone deacetylase leads to NFkappa B turnoff inhuman pancreatic carcinoma cells［J］. Mol Cancer Ther, 2010, 9(6):15961608. ［16］ Boreddy SR, Sahu RP, Srivastava SK. Benzyl isothiocyanate suppressespancreatic tumor angiogenesis and invasion by inhibiting HIFalpha/VEGF/RhoGTPases: pivotal role of STAT3［J］. PLoS One, 2011, 6(10): e25799. ［17］ Zhang R, Humphreys I, Sahu RP, et al. In vitro and in vivo induction of apoptosis by capsain in pancreaticcancer cells is mediated through ROS generation and mitochondrial death pathway［J］. Apoptosis, 2008, 13(12): 14651478．［18］ Bai H, Li H, Zhang W, et al. Inhibition of chronic pancreatitis and pancreatic intraepithelial neoplasia(PanIN) by capsaicin in LSLKrasG12D/Pdx1Cre mice［J］. Carcinogenesis, 2011, 32(11): 16891696. ［19］ Min JK, Han KY, Kim EC, et al. Capsaicin inhibits in vitro and in vivo angiogenesis［J］. Cancer Res, 2004, 64(2): 644647. ［20］ Zhang L, Pang E, Loo RR, et al. Concomitantinhibition of HSP90, its mitochondrial localized homologue TRAP1 and HSP27 by green tea in pancreatic cancer HPAFⅡ cells［J］. Proteomics, 2011, 11(24): 46384647. ［21］ Kostin SF, McDonald DE, McFadden DW. Inhibitory effects of epigallocatechin3gallate and pterostilbene on pancreatic cancer growth in vitro［J］. J Surg Res, 2012, 177(2): 255262. ［22］ Shankar S, Ganapathy S, Hingorani SR, et al. EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer［J］. Fron Biosci, 2008, 13: 440452. ［23］ Thakur VS, Gupta K, Gupta S. Green tea polyphenols increase p53transcriptional activity and acetylation by suppressing classⅠhistonedeacetylases［J］. Int J Oncol, 2012, 41(1): 353361. ［24］ Tsang WP, Kwok TT. Epigallocatechin gallate upregulation of miR16 andinduction of apoptosis in human cancer cells［J］. J Nutr Biochem, 2010, 21(2): 140146.

[1]	Kui Guoju, Huang Jiangbin, Zhang Wenhua, Yang Limin. Effect of regional lymph node diameter on postoperative recurrence in pancreatic cancer patients [J]. Journal of International Oncology, 2023, 50(10): 608-613.
[2]	Yan Zhiying, Mao Yifeng, Zhu Yingwei, Xu Kequn. Role of heterogeneity of cancer-associated fibroblasts in targeted therapy of pancreatic cancer [J]. Journal of International Oncology, 2021, 48(5): 308-312.
[3]	Zhong Yang, He Miao, Liu Zhi, Chen Jianyu, Zhang Guangnian, Qin Long, Li Ting, Li Jianshui. Effects of Ophiopogon D combined with cyclooxygenase-2 silencing on proliferation, migration and invasion of human pancreatic cancer BxPC-3 cells [J]. Journal of International Oncology, 2021, 48(10): 583-590.
[4]	Li Keke, Kong Panpan, Yi Chao, Wang Xiyan, Yan Dong. Expression of lymphoid enhancer factor-1 in pancreatic ductal adenocarcinoma and its effect on prognosis [J]. Journal of International Oncology, 2021, 48(10): 608-613.
[5]	Chen Xiaoxu, Yu Yang, Zhang Tianxue. A prognostic risk assessment model for pancreatic cancer established based on immune-related lncRNAs [J]. Journal of International Oncology, 2020, 47(8): 472-479.
[6]	Tian Chunfang, Sha Dan. Zinc finger proteins and digestive system cancers [J]. Journal of International Oncology, 2020, 47(2): 115-118.
[7]	Ji Zhouxin, He De. Microbiota and pancreatic cancer [J]. Journal of International Oncology, 2020, 47(1): 46-50.
[8]	Li Qinghe, Liu Huichun, Zhang Jiayao, Li Wei. Study on the molecular mechanism of miR-200b-3p regulates the proliferation, invasion, migration and apoptosis of pancreatic cancer cells by down-regulating VEGFA [J]. Journal of International Oncology, 2019, 46(11): 649-656.
[9]	Li Zhi, Xu Jingkai, Zhang Bo. Mechanisms of long non-coding RNAs in tumors [J]. Journal of International Oncology, 2018, 45(4): 220-222.
[10]	Ling Xiaofei, Xu Ke, Shao Hua, Wang Cuijuan. Anticancer mechanism and application of curcumin analog EF24 [J]. Journal of International Oncology, 2018, 45(3): 172-175.
[11]	Li Zhijian, He De. Research progress on liquid biopsy in pancreatic cancer [J]. Journal of International Oncology, 2018, 45(3): 180-182.
[12]	Liang Biyu, He Weiming, He Xiaoyi, Ding Yuanlin, Yu Haibing. Diabetes, hypoglycemic drugs and pancreatic cancer [J]. Journal of International Oncology, 2018, 45(3): 183-186.
[13]	Chen Luojun, Li Na, Tian Jingyuan, Xu Bin, Song Qibin. Analysis of prognosis factors in nonfunctional pancreatic neuroendocrine carcinoma [J]. Journal of International Oncology, 2018, 45(12): 721-726.
[14]	WANG Yun-Liang, LI Cui. Prognostic significance of HMGA1 and HMGA2 proteins expressions in pancreatic carcinoma [J]. Journal of International Oncology, 2017, 44(5): 346-350.
[15]	Qiao Yinbiao, Yang Bo. Research progress of HGF/c-MET signaling pathway inhibitors in antipancreatic cancer [J]. Journal of International Oncology, 2017, 44(4): 304-306.